- Company Overview for PACIRA THERAPEUTICS, INC. (FC032939)
- Filing history for PACIRA THERAPEUTICS, INC. (FC032939)
- People for PACIRA THERAPEUTICS, INC. (FC032939)
- UK establishments for PACIRA THERAPEUTICS, INC. (FC032939)
- More for PACIRA THERAPEUTICS, INC. (FC032939)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
27 Sep 2023 | OSDS01 | Closure of UK establishment(s) BR018022 and overseas company FC032939 on 7 September 2023 | |
10 Aug 2023 | AA | Group of companies' accounts made up to 31 December 2022 | |
26 Sep 2022 | AA | Group of companies' accounts made up to 31 December 2021 | |
08 Jul 2022 | OSAP01 | Appointment of Lauren Riker as a director on 19 November 2021 | |
01 Jul 2022 | OSAP01 | Appointment of Stephen Mccairns as a director on 19 November 2021 | |
01 Jul 2022 | OSAP01 | Appointment of Anthony Molloy as a director on 19 November 2021 | |
01 Jul 2022 | OSAP05 | Appointment of Stephen Mccairns as a person authorised to represent UK establishment BR018022 on 19 November 2021. | |
01 Jul 2022 | OSTM03 | Termination of appointment for a UK establishment - Transaction OSTM03- BR018022 Person Authorised to Represent terminated 19/11/2021 daniel leblanc | |
01 Jul 2022 | OSTM03 | Termination of appointment for a UK establishment - Transaction OSTM03- BR018022 Person Authorised to Represent terminated 19/11/2021 david arkowitz | |
01 Jul 2022 | OSTM03 | Termination of appointment for a UK establishment - Transaction OSTM03- BR018022 Person Authorised to Represent terminated 19/11/2021 michael clayman | |
01 Jul 2022 | OSTM01 | Termination of appointment of Neil Bodick as a director on 19 November 2021 | |
01 Jul 2022 | OSTM03 | Termination of appointment for a UK establishment - Transaction OSTM03- BR018022 Person Authorised to Represent terminated 19/11/2021 neil bodick | |
01 Jul 2022 | OSAP05 | Appointment of Lauren Riker as a person authorised to represent UK establishment BR018022 on 19 November 2021. | |
01 Jul 2022 | OSTM01 | Termination of appointment of Michael Clayman as a director on 19 November 2021 | |
29 Jun 2022 | OSAP05 | Appointment of Anthony Molloy as a person authorised to represent UK establishment BR018022 on 19 November 2021. | |
24 Jan 2022 | OSCH01 | Details changed for a UK establishment - BR018022 Name Change Flexion therapeutics, inc.,10 January 2022 | |
24 Jan 2022 | OSNM01 | Change of registered name of an overseas company on 20 January 2022 from Flexion therapeutics, inc. | |
25 Aug 2021 | AA | Group of companies' accounts made up to 31 December 2020 | |
25 Aug 2021 | AA |
Group of companies' accounts made up to 31 December 2019
|
|
26 Jun 2019 | AA | Group of companies' accounts made up to 31 December 2018 | |
05 Sep 2018 | OSAP05 | Appointment of David Arkowitz as a person authorised to represent UK establishment BR018022 on 7 May 2018. | |
31 Jul 2018 | OSTM03 | Termination of appointment for a UK establishment - Transaction OSTM03- BR018022 Person Authorised to Represent terminated 31/05/2018 frederick w driscoll | |
31 Jul 2018 | OSTM01 | Termination of appointment of Frederick W Driscoll as a director on 31 May 2018 | |
24 Jul 2018 | AA | Group of companies' accounts made up to 31 December 2017 | |
17 May 2017 | AA | Group of companies' accounts made up to 31 December 2016 |